3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Status
Active not recruiting
2
Recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Gynecologic
2
Other neoplasm
1
Conditions
Endometrial Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Carcinoma, Endometrioid
1
Adenomyosis
1
Interventions
Specimen Handling
613
pembrolizumab
563
Magnetic Resonance Spectroscopy
536
Carboplatin
425
Cisplatin
375
Cyclophosphamide
373
Biopsy
357
Paclitaxel
306
Gemcitabine
303
Nivolumab
300
Radiotherapy
260
Bevacizumab
234
Dexamethasone
209
fludarabine
205
Docetaxel
187
durvalumab
182
atezolizumab
173
Oxaliplatin
172
venetoclax
168
Fluorouracil
166
Rituximab
165
Pemetrexed
163
Capecitabine
158
Doxorubicin
157
Radiation
155
Radiosurgery
148
Etoposide
137
Leucovorin
133
Ipilimumab
133
Lenalidomide
131
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Interventional
×
Hysterectomy
×
90 days
×
Clear all
NCT07622901
2026-06-03
FIT-ENDO
University of Miami
Phase NA
Recruiting
42 enrolled
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled
NCT02598219
2026-03-18
SENTIRAD
Centre Oscar Lambret
Phase 3
Active not recruiting
262 enrolled